These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11674965)

  • 21. Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
    Tasi TN; Hsieh CH
    N Z Med J; 2004 Dec; 117(1207):U1230. PubMed ID: 15608817
    [No Abstract]   [Full Text] [Related]  

  • 22. Bilateral non-arteritic ischemic optic neuropathy associated with pegylated interferon for chronic hepatitis C.
    Chan JW
    Eye (Lond); 2007 Jun; 21(6):877-8. PubMed ID: 17318204
    [No Abstract]   [Full Text] [Related]  

  • 23. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 24. Pernicious anemia during IFN-alpha treatment for chronic hepatitis C.
    Borgia G; Reynaud L; Gentile I; Borrelli F; Cerini R; Ciampi R; Piazza M
    J Interferon Cytokine Res; 2003 Jan; 23(1):11-2. PubMed ID: 12639294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peginterferon and ribavirin for hepatitis C.
    Ben Salem C; Hmouda H; Bouraoui K
    N Engl J Med; 2007 Mar; 356(12):1270; author reply 1271. PubMed ID: 17380578
    [No Abstract]   [Full Text] [Related]  

  • 26. Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
    Borghi-Scoazec G; Merle P; Scoazec JY; Claudy A; Trepo C
    J Hepatol; 2004 May; 40(5):871-2. PubMed ID: 15094241
    [No Abstract]   [Full Text] [Related]  

  • 27. Peginterferon and ribavirin for hepatitis C.
    Evoli A; Servidei S
    N Engl J Med; 2007 Mar; 356(12):1269-70; author reply 1271. PubMed ID: 17380575
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse skin reactions associated with hepatitis C treatment: comment.
    Lübbe J
    J Dermatol; 2008 Apr; 35(4):250; author reply 251. PubMed ID: 18419688
    [No Abstract]   [Full Text] [Related]  

  • 29. [Interferon treatment in chronic HCV hepatitis and autoimmune hypothyroidism].
    Calvo Manuel E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 2000 Mar; 17(3):164-5. PubMed ID: 10804649
    [No Abstract]   [Full Text] [Related]  

  • 30. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anosmia and hypogeusia as a complication of general anesthesia.
    Dhanani NM; Jiang Y
    J Clin Anesth; 2012 May; 24(3):231-3. PubMed ID: 22495083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C.
    Rosina P; Girolomoni G
    Acta Dermatovenerol Croat; 2008; 16(1):35-7. PubMed ID: 18358108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis.
    Isler M; Akhan G; Bardak Y; Akkaya A
    Am J Gastroenterol; 2001 Apr; 96(4):1303-4. PubMed ID: 11316196
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 35. Leucopenia is a side effect of combination therapy for hepatitis C infection.
    Russo F; Bacosi M; Miglioresi L; Ricci GL
    Am J Gastroenterol; 2000 Apr; 95(4):1100-1. PubMed ID: 10763981
    [No Abstract]   [Full Text] [Related]  

  • 36. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C.
    Howaizi M
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1945-6. PubMed ID: 16336462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute pancreatitis during treatment for chronic viral hepatitis C].
    Kabbaj N; Sentissi S; Guedira MM; Mohammadi M; Benaïssa A; Amrani N
    Gastroenterol Clin Biol; 2008 Mar; 32(3):232-3. PubMed ID: 18378105
    [No Abstract]   [Full Text] [Related]  

  • 38. Generalized exfoliative dermatitis induced by interferon alfa.
    Gallelli L; Ferraro M; Mauro GF; De Sarro G
    Ann Pharmacother; 2004 Dec; 38(12):2173-4. PubMed ID: 15522975
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon-induced hepatic failure in a patient with hepatitis C.
    Lock G; Reng CM; Graeb C; Anthuber M; Wiedmann KH
    Am J Gastroenterol; 1999 Sep; 94(9):2570-1. PubMed ID: 10484034
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha].
    Drózdz W; Ziółkowska-Kochan M; Kozielewicz D; Dybowska D; Borkowska A; Halota W
    Przegl Epidemiol; 2008; 62(1):93-100. PubMed ID: 18536230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.